Can you compare the pharmacokinetics of myo-inositol versus D-chiro-inositol in managing insulin resistance and associated weight gain in lean PCOS phenotypes?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you compare the pharmacokinetics of myo-inositol versus D-chiro-inositol in managing insulin resistance and associated weight gain in lean PCOS phenotypes?
3 real searches · 1 real-search pass
myo-inositol D-chiro-inositol pharmacokinetics absorption half life renal clearance PCOS reviewGoogle ↗
OBSERVEDReason
2023 2024 international evidence based guideline PCOS inositol lean women insulin resistance weightGoogle ↗
OBSERVEDReason
myo-inositol D-chiro-inositol lean PCOS randomized trial weight insulin resistance systematic reviewGoogle ↗
OBSERVEDComparison
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
myo-inositol D-chiro-inositol pharmacokinetics absorption half life renal clearance PCOS review Google ↗
2023 2024 international evidence based guideline PCOS inositol lean women insulin resistance weight Google ↗
myo-inositol D-chiro-inositol lean PCOS randomized trial weight insulin resistance systematic review Google ↗
- Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes · pmc.ncbi.nlm.nih.gov
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines | The Journal of Clinical Endocrinology & Metabolism · academic.oup.com
- d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI) · pmc.ncbi.nlm.nih.gov
- d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI) · pmc.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors · pubmed.ncbi.nlm.nih.gov
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome | The Journal of Clinical Endocrinology & Metabolism · academic.oup.com
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines · pubmed.ncbi.nlm.nih.gov
- International Evidence-based · tjod.org
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines · pmc.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
myo-inositol D-chiro-inositol pharmacokinetics absorption half life renal clearance PCOS review OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
2023 2024 international evidence based guideline PCOS inositol lean women insulin resistance weight OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
myo-inositol D-chiro-inositol lean PCOS randomized trial weight insulin resistance systematic review OBSERVED | Google ↗ AI Mode ↗ | — | Comparison | — | — | 1x of 1 |